MyoKardia is Drug Discovery in United States that focus on genetically-driven forms business. Founded in 2012. They cover business area such as MyoKardia Inc, target therapy, serious and neglect rare cardiovascular disease, heritable cardiomyopathy, genetically-drive form, heart failure, biomechanical defect, cardiac muscle contraction, its medicine platform, an initial pipeline, therapeutic program, HCM, an orally administer small molecule, excessive cardiac muscle contractility.
2012
( 12 years old in 2024 )
Genetically-driven Forms
-
1000 Sierra Point Parkway
Brisbane, CA 94005
United States
Private
MyoKardia Inctarget therapyserious and neglect rare cardiovascular diseaseheritable cardiomyopathygenetically-drive formheart failurebiomechanical defectcardiac muscle contractionits medicine platforman initial pipelinetherapeutic programHCMan orally administer small moleculeexcessive cardiac muscle contractility
* We use standard office opening hours in near MyoKardia's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MyoKardia is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), MyoKardia business is focusing on Genetically-driven Forms.
MyoKardia headquarter office and corporate office address is located in 1000 Sierra Point Parkway Brisbane, CA 94005 United States.
MyoKardia was founded in United States.
In 2024, MyoKardia is currently focus on genetically-driven forms sector.
Above is snippet of Google Trends for "genetically-driven forms" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MyoKardia, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
